- Home
- BSET vs KZIA Comparison
BSET vs KZIA Comparison
Compare BSET & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | KZIA |
|---|---|---|
| Founded | 1902 | 1994 |
| Country | United States | Australia |
| Employees | N/A | 6 |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.9M | 186.7M |
| IPO Year | 1995 | 2002 |
Fundamental Metrics
Financial Performance| Metric | BSET | KZIA |
|---|---|---|
| Price | $18.17 | $11.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.50 |
| AVG Volume (30 Days) | 15.0K | ★ 255.7K |
| Earning Date | 04-01-2026 | 06-04-2026 |
| Dividend Yield | ★ 5.49% | N/A |
| EPS Growth | ★ 163.06 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $456,855,000.00 | N/A |
| Revenue This Year | $1.72 | N/A |
| Revenue Next Year | $3.78 | N/A |
| P/E Ratio | $49.11 | ★ N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $13.17 | $4.86 |
| 52 Week High | $22.26 | $17.40 |
Technical Indicators
Market Signals| Indicator | BSET | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 36.76 | 42.77 |
| Support Level | $14.13 | $11.39 |
| Resistance Level | $19.43 | $14.85 |
| Average True Range (ATR) | 0.55 | 1.11 |
| MACD | -0.08 | -0.26 |
| Stochastic Oscillator | 0.34 | 4.16 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.